Skip to main content

Find Clinical Trials

Home
Conditions
Chronic Lymphocytic Leukemia

Clinical trial condition

Chronic Lymphocytic Leukemia

Explore clinical trials studying Chronic Lymphocytic Leukemia. Study availability and eligibility vary by location and protocol.

526 public trials 91 recruiting studies

Refine in advanced search Browse all conditions

Chronic Lymphocytic Leukemia trial results

Active, Not Recruiting

Exercise As Intervention in Chronic Lymphocytic Leukemia

NCT06396611

Conditions: Behavior, Chronic Disease, Chronic Lymphocytic Leukemia, +16 more
Locations: Faculty of Sport of University of Porto Porto, Porto District, Portugal

View Trial Details

Active, Not Recruiting

Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL

NCT03836261

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Research Site Los Angeles, California, United States

Research Site Redondo Beach, California, United States

Research Site Fort Wayne, Indiana, United States

Research Site Wichita, Kansas, United States

View all 170 locations

View Trial Details

Active, Not Recruiting

Study to Evaluate the Safety and Preliminary Efficacy of Ibrutinib and Pembrolizumab in Patients With Chronic Lymphocytic Leukemia (CLL) or Mantle Cell Lymphoma (MCL)

NCT03153202

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

View Trial Details

Active, Not Recruiting

A Study of FCN-338 in Patients With Chronic CLL/SLL

NCT04682808

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations: SUN YAT-University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Zanubrutinib, Obinutuzumab and Lenalidomide in Newly Diagnosed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

NCT06547944

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations: Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin, Tianjin Municipality, China

View Trial Details

Active, Not Recruiting

Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib

NCT03422393

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations: UC San Diego Moores Cancer Center La Jolla, California, United States

View Trial Details